Lykos Therapeutics

Common post-traumatic stress disorder (#PTSD) symptoms may include avoidance, reoccurring distressing memories, changes in activity level and mood. Learn more about PTSD symptoms here: https://lnkd.in/eE-QTBCN 

This #IndependenceDay we recognize those who serve and fight bravely to uphold our freedoms, especially the many #Veterans who combat #PTSD every day. Thank you for your service.

It’s common for those living with #PTSD to feel triggered during #FourthOfJuly celebrations. Many may have strong reactions to fireworks due to the loud noises and flashing lights. Find more information and resources on how to cope here: https://lnkd.in/gePxWpTq

#Poll – While many Americans look forward to the #FourthOfJuly, it’s also a holiday that can trigger bad memories for individuals who have experienced traumatic events.   *If you are experiencing a crisis and need help, please call 9-1-1 

With limited treatment options, and no new FDA approved treatments in 25 years, #PTSD represents a significant unmet treatment need for ~13 million Americans each year. Read our statement in response to ICER’s Final Evidence Report on our investigational therapy for adults with PTSD here: https://lnkd.in/eb6WbQ6f

This #PTSDAwarenessDay, we’re giving those living with #PTSD a platform to share how this disease impacts their everyday lives.   Find more PTSD information and resources from Mental Health America here: https://bit.ly/3QyCb2o

While anyone can develop post-traumatic stress disorder (#PTSD), certain sociodemographic groups are more likely to experience PTSD, such as the LGBTQ+ community, Native Americans or emergency responders.   This #PTSDAwarenessMonth learn more about PTSD here: https://lnkd.in/eE-QTBCN

We appreciate the profound support and efforts of those who share a mutual commitment to improving outcomes for patients living with #PTSD. Currently, our priority is to work with the #FDA to address any outstanding questions raised during the recent FDA Advisory Committee meeting and provide information to help inform the decision-making process. Amy Emerson, CEO of Lykos Therapeutics, shares more on our next steps in an open letter here: https://lnkd.in/eeM_KjHx

#PTSD can impact anyone. #PTSD can impact anyone. #PTSD can impact anyone.   Find more PTSD information and resources from NAMI here: https://bit.ly/4buZAtK

We are committed to working alongside the FDA to address outstanding questions to find a path forward ensuring the responsible and careful introduction of our investigational therapy into the healthcare system. https://lnkd.in/eVTwBXPg